Resveratrol: Conflicting Research and Exercise Findings

What is resveratrol?

Resveratrol is a compound made by some plants, found in grape skins, red wine, and peanuts. It is not a nutrient: the body does not need it.

Supplements usually contain 100 to 600 mg of trans-resveratrol, a form also used in research, often extracted from a plant called Japanese knotweed. Trials used 150 to 2,000 mg a day. There is no official daily amount.

People take it for healthy aging, the heart, blood sugar, and the brain, often because of the “red wine” story. Actual human benefit remains questionable because metabolic reviews disagree, while one small exercise trial gave opposing results on cycling fitness and a step test.

What people take resveratrol for

When to ask a doctor before taking resveratrol

• You take regular medicines. A human study used caffeine, dextromethorphan, losartan and buspirone as test drugs and found changes in how they were processed after 1 g of resveratrol a day. That does not predict the effect on your particular medicine; ask a pharmacist to check it.
• You have Alzheimer’s disease or memory problems. The year-long trial below had mixed findings, including greater brain-volume loss of uncertain clinical meaning.

Why food is not a supplement-sized dose

Grape skins, red wine, and peanuts contain small amounts. A food-composition calculation using Chinese consumption data estimated less than 1 mg a day from food, far below the amounts in capsules. It did not survey individual people's diets.

What you can buy

Products and dosages we looked at

The examples below describe label categories. Capsules commonly list trans-resveratrol alone or as a stated percentage of Japanese knotweed extract. Compare the milligrams of trans-resveratrol, not the larger extract weight.

What to pay attention to on the label

Find the trans-resveratrol amount on the Supplement Facts panel and read the serving size. One product lists 500 mg of Japanese knotweed “standardized to 50% trans-resveratrol”: that works out to 250 mg of trans-resveratrol per serving. The 500 mg is extract weight, not the dose of the named compound. If a bottle has 180 capsules but defines a serving as three capsules, its facts panel describes three capsules and the bottle contains 60 servings.

Claims about red wine, longevity and blood sugar also need the right comparison. A glass of wine supplies far less resveratrol than a capsule; a study of 783 older Italians^[1] did not link dietary resveratrol exposure with longer life. A “supports healthy aging” line may draw on animal experiments, while a “supports healthy blood sugar” line may draw on one small positive human trial despite later conflicting results. Neither claim identifies a dependable benefit from the retail product in your hand.

What common claims leave out

Does resveratrol slow aging?

Not shown. The mouse lifespan results that made it famous were in mice on a high-fat diet; in a later program that tested it in genetically varied mice on a normal diet, it did not extend life. No human trial has shown that resveratrol extends lifespan or slows a defined measure of biological aging.

Does it help the brain?

A year-long Alzheimer’s trial found no clear memory or thinking benefit. One secondary daily-function measure favored resveratrol, while brain volume fell more; what that volume change means for symptoms is unclear.

Drawbacks and side effects

Safety details

There is no official upper limit. Nausea and diarrhea have been reported at high doses. The exercise finding is detailed below. In a study of 42 healthy adults^[2], 1 g of resveratrol daily for four weeks changed measures of how the body processed test doses of caffeine, dextromethorphan (a cough medicine), losartan (a blood-pressure medicine) and buspirone (an anxiety medicine). Researchers chose them to probe four drug-metabolizing enzyme pathways. The study did not test whether continuing any of those medicines with resveratrol changes its benefit or side effects, or predict what happens with every other drug using those pathways. Ask a pharmacist to check your actual medication list before taking a concentrated resveratrol product.

Supporting trial detail

Absorption and blood exposure

In a 2004 human study^[3], at least 70% of a 25 mg oral dose was absorbed, but the gut and liver rapidly converted most of it into other compounds. Only traces of unchanged resveratrol reached the blood. The converted forms may have biological effects, but this study did not establish a health benefit. Resveratrol dissolves better in fat than in water; taking it in yogurt or with a meal has not been shown to improve clinical outcomes.

Blood sugar and metabolism

A 2011 trial in 11 men with obesity found lower systolic blood pressure, blood glucose and triglycerides after 150 mg a day for 30 days. HOMA, an estimate of insulin resistance, also improved. The product came from DSM, a company that sells resveratrol, and a company researcher was an author. Later trials did not find a clear difference in their main insulin-sensitivity tests: one analyzed 24 men after 1,500 mg a day for four weeks, and a six-month trial of 150 mg a day completed with 41 adults. The six-month trial did find lower HbA1c, a longer-term blood-sugar measure. This was an additional measure, not the main question the trial was designed to answer. Testing many measures makes a chance positive result more likely; the analysis did not account for that. Reviews since then disagree.

The 2022 review by Zhou and colleagues^[4] reported lower HbA1c and LDL cholesterol, while fasting glucose and triglycerides were not significantly different. The results varied greatly across studies. Its study table misprints the doses of two trials: 150 mg and 1,500 mg appear as 50 mg and 150 mg, respectively.

A 2026 review of 10 meta-analyses in type 2 diabetes^[5] concluded that resveratrol was not beneficial overall, yet its abstract also reports a statistically significant LDL reduction in one analysis. Reviews can also reuse the same trials; they are not independent new groups of participants.

Exercise

In a 2013 trial^[6], 27 inactive men aged 60–72 took 250 mg of trans-resveratrol a day or placebo during eight weeks of cycling, circuit training and walking. Both groups became fitter. A cycling test measured the maximum amount of oxygen they could use per minute, a measure of aerobic fitness. The increase was about 443 mL/min with placebo and 308 mL/min with resveratrol; the difference was statistically significant.

An additional step test estimated aerobic fitness and pointed the other way: its oxygen estimate rose from 29.3 to 36.0 mL/kg/min with resveratrol and 28.3 to 31.9 with placebo. Those are starting and ending values per kilogram of body weight; the cycling numbers above are increases for the whole body. The trial authors acknowledged^[7] this favorable secondary finding while maintaining their overall concern about training adaptations. Walking and chair-stand performance improved in both groups; balance did not.

The claim that resveratrol abolished cholesterol and blood-pressure benefits is disputed. LDL fell from 3.3 to 3.0 mmol/L with placebo and 3.6 to 3.4 with resveratrol. Only the first change passed the significance threshold; that alone does not show a difference between treatments. Published letters^[8] challenged the broader harm interpretation.

Alzheimer’s disease

In a 52-week trial of 119 people^[9] with mild to moderate Alzheimer’s disease, participants started at 500 mg of resveratrol a day and gradually increased to 2,000 mg a day, or took placebo. Memory and thinking tests showed no clear benefit. Daily functioning declined in both groups, but one secondary measure declined less with resveratrol—a preliminary positive finding among many comparisons. MRI showed greater brain-volume loss in the resveratrol group. The investigators could not determine what that change meant clinically; the resveratrol group did not have worse cognitive or daily-function results than the placebo group. The study was designed mainly to assess safety and changes in disease-related measurements, rather than to establish treatment benefit.

Aging

Resveratrol extended the lives of mice on a high-fat diet in a 2006 study. In a 2011 U.S. program that tests drugs in genetically varied mice, it did not extend life. What is still open is whether any dose improves a health outcome in people.

What you may have heard on podcasts

Guests disagree. David Sinclair (FoundMyFitness, 6 November 2019) said he takes about half a gram to a gram (500 to 1,000 mg) of trans-resveratrol each morning in yogurt because he thinks its fat helps dissolve the compound. He co-founded Sirtris, a company that developed drugs based on resveratrol.

Andrew Huberman (Huberman Lab, 31 October 2023) said the idea that resveratrol extends lifespan has been debunked, noting “very little, if any, direct evidence” for it. Peter Attia (Huberman Lab, 29 July 2024) said the U.S. mouse testing program found it did “categorically nothing.”

The 2011 U.S. mouse program^[10] tested resveratrol in genetically varied mice eating a standard diet and found no lifespan extension. That differs from the earlier high-fat-diet mouse experiment that helped popularize resveratrol. Human trials have tested amounts in and above Sinclair’s range, including 1,500 and 2,000 mg a day, without establishing a lifespan benefit or clear improvement in insulin sensitivity or cognition.

The bottom line

Resveratrol has an appealing anti-aging story, but human trials have not established longer life or a dependable metabolic benefit. One small exercise trial found smaller cycling-fitness gains alongside a better secondary step-test result; its broader claims of harm remain disputed.

Help us improve this article

Spotted an error or found a source we should consider? Tell us which part of this article needs another look and include a link if you have one. Please leave out personal health details and lab results; we can’t answer individual medical questions.

Your name

Email address

What would you like to share?Select a topicCorrectionSource or research suggestionArticle requestAccessibility issueBusiness inquirySomething else

Your message

Continue to email →Email us directly